Vident Investment Advisory, LLC Macrogenics Inc Transaction History

Vident Investment Advisory, LLC

$0
Q3 2023

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.25 - $9.99 $155,931 - $692,336	-69,303 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$8.12 - $16.9 $93,785 - $195,194	11,550 Added 20.0%	69,303 $611,000
Q4 2021 Feb 14, 2022	SELL	$15.91 - $21.88 $140,008 - $192,544	-8,800 Reduced 13.22%	57,753 $927,000
Q3 2021 Nov 12, 2021	SELL	$19.74 - $28.7 $93,843 - $136,439	-4,754 Reduced 6.67%	66,553 $1.39 Million
Q2 2021 Aug 13, 2021	SELL	$20.49 - $35.63 $13,933 - $24,228	-680 Reduced 0.94%	71,307 $1.92 Million
Q4 2020 Feb 08, 2021	BUY	$19.41 - $26.0 $179,134 - $239,954	9,229 Added 14.71%	71,987 $1.65 Million
Q3 2020 Nov 12, 2020	SELL	$24.69 - $31.6 $107,203 - $137,207	-4,342 Reduced 6.47%	62,758 $1.58 Million
Q2 2020 Jul 17, 2020	BUY	$5.2 - $29.12 $348,920 - $1.95 Million	67,100 New	67,100 $1.87 Million
Q4 2019 Feb 11, 2020	SELL	$7.95 - $12.27 $733,618 - $1.13 Million	-92,279 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$12.44 - $17.48 $32,791 - $46,077	-2,636 Reduced 2.78%	92,279 $1.18 Million
Q2 2019 Aug 12, 2019	SELL	$14.51 - $19.71 $143,010 - $194,261	-9,856 Reduced 9.41%	94,915 $1.61 Million
Q1 2019 May 08, 2019	SELL	$11.11 - $25.6 $41,862 - $96,460	-3,768 Reduced 3.47%	104,771 $1.88 Million
Q4 2018 Feb 14, 2019	BUY	$11.75 - $21.42 $47,622 - $86,815	4,053 Added 3.88%	108,539 $1.38 Million
Q3 2018 Nov 14, 2018	SELL	$19.26 - $23.46 $134,107 - $163,351	-6,963 Reduced 6.25%	104,486 $2.24 Million
Q2 2018 Aug 14, 2018	BUY	$19.78 - $24.67 $429,542 - $535,733	21,716 Added 24.2%	111,449 $2.3 Million
Q1 2018 May 14, 2018	BUY	$18.89 - $32.46 $455,060 - $781,961	24,090 Added 36.7%	89,733 $2.18 Million
Q4 2017 Feb 15, 2018	BUY	$16.19 - $20.3 $6,055 - $7,592	374 Added 0.57%	65,643 $1.25 Million
Q3 2017 Nov 14, 2017	BUY	$15.52 - $18.94 $1.01 Million - $1.24 Million	65,269	65,269 $1.21 Million

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

Bellevue Group Ag Kuesnacht, V8

9.93M
Shares

$32.4 Million
0.55% of portfolio
Armistice Capital, LLC New York, NY

6.26M
Shares

$20.4 Million
0.34% of portfolio
Black Rock Inc. New York, NY

5.4M
Shares

$17.6 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.36M
Shares

$14.2 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.54M
Shares

$11.5 Million
0.01% of portfolio

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Account